Global Major Depressive Disorder Drug Industry Research Report 2020, Forecast to 2025

August 2020 | 100 pages | ID: G045BB130042EN
WKinformation

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The Major Depressive Disorder Drug market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Major Depressive Disorder Drug is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.

The report offers detailed coverage of Major Depressive Disorder Drug industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Major Depressive Disorder Drug by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Major Depressive Disorder Drug market are discussed.

The market is segmented by types:

• Drugs Therapy
• Biological Therapy
• Meditation
• Physiotherapy
• Other

It can be also divided by applications:

• Under 25 Years Old
• 25-45 Years Old
• Above 45 Years Old

And this report covers the historical situation, present status and the future prospects of the global Major Depressive Disorder Drug market for 2015-2025. In this report, we analyze global market from 5 geographies: Asia-Pacific, Europe, North America, Middle East & Africa, South America.

Finally, the report provides detailed profile and data information analysis of leading company.

• Pfizer
• Naurex
• Otsuka Pharmaceutical
• Eli Lilly
• Takeda Pharmaceutical
• H. Lundbeck
• E-therapeutics
• Alkermes
• AstraZeneca
• Euthymics Bioscience

Report Includes:

• xx data tables and xx additional tables
• An overview of global Major Depressive Disorder Drug market
• An detailed key players analysis across regions
• Analyses of global market trends, with historical data, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
• Insights into regulatory and environmental developments
• Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Major Depressive Disorder Drug market
• Profiles of major players in the industry, including Pfizer, Naurex, Otsuka Pharmaceutical, Eli Lilly, Takeda Pharmaceutical.....

Research Objectives

• To study and analyze the global Major Depressive Disorder Drug consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.
• To understand the structure of Major Depressive Disorder Drug market by identifying its various subsegments.
• Focuses on the key global Major Depressive Disorder Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
• To analyze the Major Depressive Disorder Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Major Depressive Disorder Drug submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

Global Major Depressive Disorder Drug Market Report 2020, Forecast to 2025

1 SCOPE OF THE STUDY

1.1 Major Depressive Disorder Drug Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives

2 MAJOR DEPRESSIVE DISORDER DRUG INDUSTRY OVERVIEW

2.1 Global Major Depressive Disorder Drug Market Size (Million USD) Comparison by Regions (2020-2025)
  2.1.1 Major Depressive Disorder Drug Global Import Market Analysis
  2.1.2 Major Depressive Disorder Drug Global Export Market Analysis
  2.1.3 Major Depressive Disorder Drug Global Main Region Market Analysis
2.2 Market Analysis by Type
  2.2.1 Drugs Therapy
  2.2.2 Biological Therapy
  2.2.3 Meditation
  2.2.4 Physiotherapy
  2.2.5 Other
2.3 Market Analysis by Application
  2.3.1 Under 25 Years Old
  2.3.2 25-45 Years Old
  2.3.3 Above 45 Years Old
2.4 Global Major Depressive Disorder Drug Revenue, Sales and Market Share by Manufacturer
  2.4.1 Global Major Depressive Disorder Drug Sales and Market Share by Manufacturer (2018-2020)
  2.4.2 Global Major Depressive Disorder Drug Revenue and Market Share by Manufacturer (2018-2020)
  2.4.3 Global Major Depressive Disorder Drug Industry Concentration Ratio (CR5 and HHI)
  2.4.4 Top 5 Major Depressive Disorder Drug Manufacturer Market Share
  2.4.5 Top 10 Major Depressive Disorder Drug Manufacturer Market Share
  2.4.6 Date of Key Manufacturers Enter into Major Depressive Disorder Drug Market
  2.4.7 Key Manufacturers Major Depressive Disorder Drug Product Offered
  2.4.8 Mergers & Acquisitions Planning
2.5 Major Depressive Disorder Drug Historical Development Overview
2.6 Market Dynamics
  2.6.1 Market Opportunities
  2.6.2 Market Risk
  2.6.3 Market Driving Force
  2.6.4 Porter's Five Forces Analysis
2.7 Coronavirus Disease 2019 (Covid-19): Major Depressive Disorder Drug Industry Impact
  2.7.1 How the Covid-19 is Affecting the Major Depressive Disorder Drug Industry
  2.7.2 Major Depressive Disorder Drug Business Impact Assessment - Covid-19
  2.7.3 Market Trends and Major Depressive Disorder Drug Potential Opportunities in the COVID-19 Landscape
  2.7.4 Measures / Proposal against Covid-19

3 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS

3.1 Upstream Analysis
  3.1.1 Macro Analysis of Upstream Markets
  3.1.2 Key Players in Upstream Markets
  3.1.3 Upstream Market Trend Analysis
  3.1.4 Major Depressive Disorder Drug Manufacturing Cost Analysis
3.2 Downstream Market Analysis
  3.2.1 Macro Analysis of Down Markets
  3.2.2 Key Players in Down Markets
  3.2.3 Downstream Market Trend Analysis
  3.2.4 Sales Channel, Distributors, Traders and Dealers

4 GLOBAL MAJOR DEPRESSIVE DISORDER DRUG MARKET SIZE CATEGORIZED BY REGIONS (2015-2020)

4.1 Global Major Depressive Disorder Drug Sales Market Share by Region
4.2 Global Major Depressive Disorder Drug Revenue Market Share by Region (2015-2019)
4.3 Global Major Depressive Disorder Drug Sales, Revenue, Price and Gross Margin (2015-2020)
4.4 North America Major Depressive Disorder Drug Market Size Detail
  4.4.1 North America Major Depressive Disorder Drug Sales Growth Rate (2015-2020)
  4.4.2 North America Major Depressive Disorder Drug Sales, Revenue, Price and Gross Margin (2015-2020)
4.5 Europe Major Depressive Disorder Drug Market Size Detail
  4.5.1 Europe Major Depressive Disorder Drug Sales Growth Rate (2015-2020)
  4.5.2 Europe Major Depressive Disorder Drug Sales, Revenue, Price and Gross Margin (2015-2020)
4.6 Japan Major Depressive Disorder Drug Market Size Detail
  4.6.1 Japan Major Depressive Disorder Drug Sales Growth Rate (2015-2020)
  4.6.2 Japan Major Depressive Disorder Drug Sales, Revenue, Price and Gross Margin (2015-2020)
4.7 China Major Depressive Disorder Drug Market Size Detail
  4.7.1 China Major Depressive Disorder Drug Sales Growth Rate (2015-2020)
  4.7.2 China Major Depressive Disorder Drug Sales, Revenue, Price and Gross Margin (2015-2020)

5 GLOBAL MAJOR DEPRESSIVE DISORDER DRUG MARKET SEGMENT BY TYPE

5.1 Global Major Depressive Disorder Drug Revenue, Sales and Market Share by Type (2015-2020)
  5.1.1 Global Major Depressive Disorder Drug Sales and Market Share by Type (2015-2020)
  5.1.2 Global Major Depressive Disorder Drug Revenue and Market Share by Type (2015-2020)
5.2 Drugs Therapy Sales Growth Rate and Price
  5.2.1 Global Drugs Therapy Sales Growth Rate (2015-2020)
  5.2.2 Global Drugs Therapy Price (2015-2020)
5.3 Biological Therapy Sales Growth Rate and Price
  5.3.1 Global Biological Therapy Sales Growth Rate (2015-2020)
  5.3.2 Global Biological Therapy Price (2015-2020)
5.4 Meditation Sales Growth Rate and Price
  5.4.1 Global Meditation Sales Growth Rate (2015-2020)
  5.4.2 Global Meditation Price (2015-2020)
5.5 Physiotherapy Sales Growth Rate and Price
  5.5.1 Global Physiotherapy Sales Growth Rate (2015-2020)
  5.5.2 Global Physiotherapy Price (2015-2020)
5.6 Other Sales Growth Rate and Price
  5.6.1 Global Other Sales Growth Rate (2015-2020)
  5.6.2 Global Other Price (2015-2020)

6 GLOBAL MAJOR DEPRESSIVE DISORDER DRUG MARKET SEGMENT BY APPLICATION

6.1 Global Major Depressive Disorder DrugSales Market Share by Application (2015-2020)
6.2 Under 25 Years Old Sales Growth Rate (2015-2020)
6.3 25-45 Years Old Sales Growth Rate (2015-2020)
6.4 Above 45 Years Old Sales Growth Rate (2015-2020)

7 GLOBAL MAJOR DEPRESSIVE DISORDER DRUG MARKET FORECAST

7.1 Global Major Depressive Disorder Drug Sales, Revenue Forecast
  7.1.1 Global Major Depressive Disorder Drug Sales Growth Rate Forecast (2020-2025)
  7.1.2 Global Major Depressive Disorder Drug Revenue and Growth Rate Forecast (2020-2025)
  7.1.3 Global Major Depressive Disorder Drug Price and Trend Forecast (2020-2025)
7.2 Global Major Depressive Disorder Drug Sales Forecast by Region (2020-2025)
  7.2.1 North America Major Depressive Disorder Drug Sales, Revenue Forecast (2020-2025)
  7.2.2 Europe Major Depressive Disorder Drug Sales, Revenue Forecast (2020-2025)
  7.2.3 Japan Major Depressive Disorder Drug Production, Revenue Forecast (2020-2025)
  7.2.4 China Major Depressive Disorder Drug Production, Revenue Forecast (2020-2025)

8 ANALYSIS OF MAJOR DEPRESSIVE DISORDER DRUG INDUSTRY KEY MANUFACTURERS

8.1 Pfizer
  8.1.1 Company Details
  8.1.2 Product Information
  8.1.3 Pfizer Major Depressive Disorder Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.1.4 Main Business Overview
  8.1.5 Pfizer News
8.2 Naurex
  8.2.1 Company Details
  8.2.2 Product Information
  8.2.3 Naurex Major Depressive Disorder Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.2.4 Main Business Overview
  8.2.5 Naurex News
8.3 Otsuka Pharmaceutical
  8.3.1 Company Details
  8.3.2 Product Information
  8.3.3 Otsuka Pharmaceutical Major Depressive Disorder Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.3.4 Main Business Overview
  8.3.5 Otsuka Pharmaceutical News
8.4 Eli Lilly
  8.4.1 Company Details
  8.4.2 Product Information
  8.4.3 Eli Lilly Major Depressive Disorder Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.4.4 Main Business Overview
  8.4.5 Eli Lilly News
8.5 Takeda Pharmaceutical
  8.5.1 Company Details
  8.5.2 Product Information
  8.5.3 Takeda Pharmaceutical Major Depressive Disorder Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.5.4 Main Business Overview
  8.5.5 Takeda Pharmaceutical News
8.6 H. Lundbeck
  8.6.1 Company Details
  8.6.2 Product Information
  8.6.3 H. Lundbeck Major Depressive Disorder Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.6.4 Main Business Overview
  8.6.5 H. Lundbeck News
8.7 E-therapeutics
  8.7.1 Company Details
  8.7.2 Product Information
  8.7.3 E-therapeutics Major Depressive Disorder Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.7.4 Main Business Overview
  8.7.5 E-therapeutics News
8.8 Alkermes
  8.8.1 Company Details
  8.8.2 Product Information
  8.8.3 Alkermes Major Depressive Disorder Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.8.4 Main Business Overview
  8.8.5 Alkermes News
8.9 AstraZeneca
  8.9.1 Company Details
  8.9.2 Product Information
  8.9.3 AstraZeneca Major Depressive Disorder Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.9.4 Main Business Overview
  8.9.5 AstraZeneca News
8.10 Euthymics Bioscience
  8.10.1 Company Details
  8.10.2 Product Information
  8.10.3 Euthymics Bioscience Major Depressive Disorder Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.10.4 Main Business Overview
  8.10.5 Euthymics Bioscience News

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Major Depressive Disorder Drug Picture
Figure Research Programs/Design for This Report
Figure Global Major Depressive Disorder Drug Market by Regions (2019)
Table Global Market Major Depressive Disorder Drug Comparison by Regions (M USD) 2019-2025
Table Global Major Depressive Disorder Drug Sales Growth (CAGR) (2019-2025) by Type
Figure Global Sales Market Share of Major Depressive Disorder Drug by Type in 2019
Figure Drugs Therapy Picture
Figure Biological Therapy Picture
Figure Meditation Picture
Figure Physiotherapy Picture
Figure Other Picture
Table Global Major Depressive Disorder Drug Sales by Application (2019-2025)
Figure Global Major Depressive Disorder Drug Sales Market Share by Application in 2019
Figure Under 25 Years Old Picture
Figure 25-45 Years Old Picture
Figure Above 45 Years Old Picture
Table Global Major Depressive Disorder Drug Sales by Manufacturer (2018-2020)
Figure Global Major Depressive Disorder Drug Sales Market Share by Manufacturer in 2019
Table Global Major Depressive Disorder Drug Revenue by Manufacturer (2018-2020)
Figure Global Major Depressive Disorder Drug Revenue Market Share by Manufacturer in 2019
Table Global Major Depressive Disorder Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Major Depressive Disorder Drug Manufacturer (Revenue) Market Share in 2019
Figure Top 10 Major Depressive Disorder Drug Manufacturer (Revenue) Market Share in 2019
Table Date of Key Manufacturers Enter into Major Depressive Disorder Drug Market
Table Key Manufacturers Major Depressive Disorder Drug Product Type
Table Mergers & Acquisitions Planning
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Major Depressive Disorder Drug
Table Key Players of Upstream Markets
Figure Sales Channel
Table Global Major Depressive Disorder Drug Sales (K Units) by Region (2015-2020)
Table Global Major Depressive Disorder Drug Sales Market Share by Region (2015-2019)
Figure Global Major Depressive Disorder Drug Sales Market Share by Region (2015-2019)
Figure Global Major Depressive Disorder Drug Sales Market Share by Region in 2018
Table Global Major Depressive Disorder Drug Revenue (Million US$) by Region (2015-2020)
Table Global Major Depressive Disorder Drug Revenue Market Share by Region (2015-2020)
Figure Global Major Depressive Disorder Drug Revenue Market Share by Region (2015-2020)
Figure Global Major Depressive Disorder Drug Revenue Market Share by Region in 2019
Table Global Major Depressive Disorder Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure North America Major Depressive Disorder Drug Sales (K Units) Growth Rate (2015-2020)
Table North America Major Depressive Disorder Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Europe Major Depressive Disorder Drug Sales (K Units) Growth Rate (2015-2020)
Table Europe Major Depressive Disorder Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Japan Major Depressive Disorder Drug Sales (K Units) Growth Rate (2015-2020)
Table Japan Major Depressive Disorder Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure China Major Depressive Disorder Drug Sales (K Units) Growth Rate (2015-2020)
Table China Major Depressive Disorder Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table Global Major Depressive Disorder Drug Sales by Type (2015-2020)
Table Global Major Depressive Disorder Drug Sales Market Share by Type (2015-2020)
Figure Global Major Depressive Disorder Drug Sales Market Share by Type in 2019
Table Global Major Depressive Disorder Drug Revenue by Type (2015-2020)
Table Global Major Depressive Disorder Drug Revenue Market Share by Type (2015-2020)
Figure Global Major Depressive Disorder Drug Revenue Market Share by Type in 2019
Figure Global Drugs Therapy Sales Growth Rate (2015-2020)
Figure Global Drugs Therapy Price (2015-2020)
Figure Global Biological Therapy Sales Growth Rate (2015-2020)
Figure Global Biological Therapy Price (2015-2020)
Figure Global Meditation Sales Growth Rate (2015-2020)
Figure Global Meditation Price (2015-2020)
Figure Global Physiotherapy Sales Growth Rate (2015-2020)
Figure Global Physiotherapy Price (2015-2020)
Figure Global Other Sales Growth Rate (2015-2020)
Figure Global Other Price (2015-2020)
Table Global Major Depressive Disorder Drug Sales by Application (2015-2020)
Table Global Major Depressive Disorder Drug Sales Market Share by Application (2015-2020)
Figure Global Major Depressive Disorder Drug Sales Market Share by Application in 2019
Figure Global Under 25 Years Old Sales Growth Rate (2015-2020)
Figure Global 25-45 Years Old Sales Growth Rate (2015-2020)
Figure Global Above 45 Years Old Sales Growth Rate (2015-2020)
Figure Global Major Depressive Disorder Drug Production (K Units) Growth Rate Forecast (2020-2025)
Figure Global Major Depressive Disorder Drug Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Global Major Depressive Disorder Drug Price and Trend Forecast (2020-2025)
Table Global Major Depressive Disorder Drug Sales (K Units) Forecast by Region (2020-2025)
Figure Global Major Depressive Disorder Drug Production Market Share Forecast by Region (2020-2025)
Figure North America Major Depressive Disorder Drug Sales (K Units) Growth Rate Forecast (2020-2025)
Figure North America Major Depressive Disorder Drug Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Europe Major Depressive Disorder Drug Sales (K Units) Growth Rate Forecast (2020-2025)
Figure Europe Major Depressive Disorder Drug Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Japan Major Depressive Disorder Drug Production (K Units) Growth Rate Forecast (2020-2025)
Figure Japan Major Depressive Disorder Drug Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure China Major Depressive Disorder Drug Production (K Units) Growth Rate Forecast (2020-2025)
Figure China Major Depressive Disorder Drug Revenue (Million US$) Growth Rate Forecast (2020-2025)
Table Pfizer Company Profile
Figure Major Depressive Disorder Drug Product Picture and Specifications of Pfizer
Table Major Depressive Disorder Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Pfizer Major Depressive Disorder Drug Market Share (2018-2020)
Table Pfizer Main Business
Table Pfizer Recent Development
Table Naurex Company Profile
Figure Major Depressive Disorder Drug Product Picture and Specifications of Naurex
Table Major Depressive Disorder Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Naurex Major Depressive Disorder Drug Market Share (2018-2020)
Table Naurex Main Business
Table Naurex Recent Development
Table Otsuka Pharmaceutical Company Profile
Figure Major Depressive Disorder Drug Product Picture and Specifications of Otsuka Pharmaceutical
Table Major Depressive Disorder Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Otsuka Pharmaceutical Major Depressive Disorder Drug Market Share (2018-2020)
Table Otsuka Pharmaceutical Main Business
Table Otsuka Pharmaceutical Recent Development
Table Eli Lilly Company Profile
Figure Major Depressive Disorder Drug Product Picture and Specifications of Eli Lilly
Table Major Depressive Disorder Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Eli Lilly Major Depressive Disorder Drug Market Share (2018-2020)
Table Eli Lilly Main Business
Table Eli Lilly Recent Development
Table Takeda Pharmaceutical Company Profile
Figure Major Depressive Disorder Drug Product Picture and Specifications of Takeda Pharmaceutical
Table Major Depressive Disorder Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Takeda Pharmaceutical Major Depressive Disorder Drug Market Share (2018-2020)
Table Takeda Pharmaceutical Main Business
Table Takeda Pharmaceutical Recent Development
Table H. Lundbeck Company Profile
Figure Major Depressive Disorder Drug Product Picture and Specifications of H. Lundbeck
Table Major Depressive Disorder Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure H. Lundbeck Major Depressive Disorder Drug Market Share (2018-2020)
Table H. Lundbeck Main Business
Table H. Lundbeck Recent Development
Table E-therapeutics Company Profile
Figure Major Depressive Disorder Drug Product Picture and Specifications of E-therapeutics
Table Major Depressive Disorder Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure E-therapeutics Major Depressive Disorder Drug Market Share (2018-2020)
Table E-therapeutics Main Business
Table E-therapeutics Recent Development
Table Alkermes Company Profile
Figure Major Depressive Disorder Drug Product Picture and Specifications of Alkermes
Table Major Depressive Disorder Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Alkermes Major Depressive Disorder Drug Market Share (2018-2020)
Table Alkermes Main Business
Table Alkermes Recent Development
Table AstraZeneca Company Profile
Figure Major Depressive Disorder Drug Product Picture and Specifications of AstraZeneca
Table Major Depressive Disorder Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure AstraZeneca Major Depressive Disorder Drug Market Share (2018-2020)
Table AstraZeneca Main Business
Table AstraZeneca Recent Development
Table Euthymics Bioscience Company Profile
Figure Major Depressive Disorder Drug Product Picture and Specifications of Euthymics Bioscience
Table Major Depressive Disorder Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Euthymics Bioscience Major Depressive Disorder Drug Market Share (2018-2020)
Table Euthymics Bioscience Main Business
Table Euthymics Bioscience Recent Development
Table of Appendix